Web www.globalrph.com
PLEASE READ THE DISCLAIMER CAREFULLY BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER.  References     Disclaimer  

Bivalirudin
Angiomax ® - Renal dosing
Usual Dosing (Adults)

Anticoagulant in patients with unstable angina undergoing percutaneous transluminal coronary angioplasty (PTCA). 
Dosing:  Initially, IV bolus: 0.75 mg/kg, followed by an infusion of 1.75 mg/kg/hour for the duration of the procedure.  Determine ACT 5 minutes after bolus dose has been administered. 
Continuation of the Angiomax infusion following PCI for up to 4 hours post-procedure is optional, at the discretion of the treating physician. After 4 hours, an additional IV infusion of Angiomax may be initiated at a rate of 0.2 mg/kg/h for up to 20 hours, if needed.

Renal Dosing
Initial bolus dose remains unchanged. Monitor activated coagulation time (ACT).
[> 30 ml/min]: No adjustment required
[10-29 ml/min]: Decrease infusion rate to 1 mg/kg/hour.
Hemodialysis
Dialysis-dependent patients (off dialysis): Decrease infusion rate to 0.25 mg/kg/hour. No reduction in the bolus dose is needed.


 

 

Contact . Privacy PolicyDisclaimer

Copyright  © GlobalRPh Inc.